PubRank

Joost P Schanstra

Author PubWeight™ 64.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res 2008 2.12
2 Urine in clinical proteomics. Mol Cell Proteomics 2008 2.05
3 Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005 1.97
4 Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010 1.90
5 Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010 1.59
6 CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2008 1.57
7 Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 2007 1.56
8 Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006 1.52
9 Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 2007 1.52
10 LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol 2007 1.51
11 Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 2010 1.48
12 Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet 2014 1.44
13 Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev 2009 1.19
14 Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics 2010 1.16
15 Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl 2010 1.12
16 The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 2009 1.11
17 Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta 2008 1.04
18 CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 2010 1.02
19 The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl 2008 1.01
20 Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012 1.00
21 Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol 2010 0.99
22 Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 2008 0.96
23 Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin Investig Drugs 2011 0.94
24 Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation 2002 0.90
25 Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol 2008 0.90
26 Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One 2013 0.90
27 A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem 2002 0.90
28 Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol 2002 0.89
29 Clinical proteomics in obstetrics and neonatology. Expert Rev Proteomics 2014 0.88
30 Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis 2010 0.88
31 Non-invasive markers of ureteropelvic junction obstruction. World J Urol 2007 0.88
32 Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med 2013 0.87
33 Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol 2009 0.87
34 The KUPKB: a novel Web application to access multiomics data on kidney disease. FASEB J 2012 0.87
35 Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments. Anal Bioanal Chem 2008 0.87
36 Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem 2006 0.86
37 Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor. Biochem Biophys Res Commun 2009 0.85
38 Renal fibrosis: insight from proteomics in animal models and human disease. Proteomics 2011 0.84
39 Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. Am J Physiol Renal Physiol 2012 0.84
40 Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant 2010 0.84
41 Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis. Exp Biol Med (Maywood) 2009 0.84
42 Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis. Pancreas 2016 0.84
43 Renal tubular fluid shear stress promotes endothelial cell activation. Biochem Biophys Res Commun 2011 0.83
44 Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int 2002 0.82
45 Bradykinin and renal fibrosis: have we ACE'd it? J Am Soc Nephrol 2004 0.81
46 Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene. Regul Pept 2007 0.81
47 [Bradykinin receptors: towards new pathophysiological roles]. Med Sci (Paris) 2003 0.81
48 Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction. Regul Pept 2007 0.80
49 miRNAs in urine: a mirror image of kidney disease? Expert Rev Mol Diagn 2015 0.80
50 Hnf-1β transcription factor is an early hif-1α-independent marker of epithelial hypoxia and controls renal repair. PLoS One 2013 0.80
51 Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes. Biol Chem 2006 0.79
52 Systems biology to battle vascular disease. Nephrol Dial Transplant 2010 0.78
53 Renal and urinary proteomics. Proteomics Clin Appl 2011 0.78
54 Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling. J Urol 2012 0.77
55 The KUPNetViz: a biological network viewer for multiple -omics datasets in kidney diseases. BMC Bioinformatics 2013 0.77
56 Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin. Nephrol Dial Transplant 2010 0.77
57 Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications. Bioanalysis 2014 0.77
58 Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment. Proteomics 2013 0.76
59 Transcriptional regulation of the rat bradykinin B2 receptor gene: identification of a silencer element. Mol Pharmacol 2002 0.76
60 [Renal urinary shear stress: a novel actor in nephropathies]. Med Sci (Paris) 2013 0.76
61 Direct protein-protein interaction between PLCgamma1 and the bradykinin B2 receptor--importance of growth conditions. Biochem Biophys Res Commun 2005 0.76
62 Molecular structure and transcriptional regulation by nuclear factor-kappaB of the mouse kinin B1 receptor gene. Biol Chem 2005 0.76
63 Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products. PLoS One 2013 0.75
64 Is the time ripe for kidney tissue proteomics? Proteomics Clin Appl 2011 0.75
65 [Tubulo-interstitial fibrosis: an emerging major health problem]. Med Sci (Paris) 2011 0.75